Renal Medullary Carcinoma (RMC): Symptoms, Causes, Diagnosis, and Management
Updated: Nov 11
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Quick Answer: What is renal medullary carcinoma?
Renal medullary carcinoma (RMC) is a rare, exceptionally aggressive kidney cancer that forms deep in the kidney's medulla. [3] It is most common in teens and young adults, particularly Black males with sickle cell trait or disease. Blood in the urine is the most common early sign. [4] Treatment involves chemotherapy and possibly surgery, and median survival is approximately 12 months.
What the research says
Most cases are found late and linked to sickle cell trait. A review of 224 cases (219 published and 5 new) found 88% of patients had a sickle cell hemoglobin variant and 70.9% already had stage IV disease; 3-year survival was 74% for stage I-II but 9% for stage IV (Weston et al., Int Urol Nephrol, 2026) [3].
Blood in the urine is the most common first sign. In 135 patients treated at one cancer center, 78% had spread at diagnosis, hematuria was the most frequent first symptom (60%), and survival improved in more recent years (Lebenthal et al., Eur Urol Oncol, 2025) [4].
Who is at risk of renal medullary carcinoma (RMC), and how common is it?
RMC is a distinct zebra among kidney cancers, with specific risk factors that set it apart from more common types.
RMC Risk Profile
Factor | High-Risk Category | Notes |
Genetic Condition | Sickle Cell Trait or Disease | Almost all RMC patients have one of these conditions. |
Age Group | 11 to 39 years old | Most common in teens and young adults. |
Biological Sex | Male | Males are 2 to 3 times more likely to develop RMC. |
Race | Black | In the U.S., the majority of cases are among Black individuals. |
Prevalence | <1% of kidney cancers | Extremely rare on a global scale. |

What are the symptoms and warning signs of renal medullary carcinoma?
Because RMC spreads rapidly, recognizing early symptoms is critical for starting treatment as soon as possible.
Common Symptoms
Hematuria: Blood in the urine is usually the first noticeable sign. [4]
Lower Back Pain: Pain typically localized to the side of the affected kidney (most often the right side).
Abdominal Mass: A lump or mass felt in the lower back or just below the ribcage.
Systemic Signs: Fever, night sweats, and unexplained weight loss.
Diagnostic Timeline
Initial Screening: Imaging tests (CT or MRI) to locate the primary tumor. [2]
Staging: Full-body CT or PET scans to check for metastasis (spread), which is common at diagnosis.
Confirmation: A needle biopsy to collect tissue for lab analysis by a pathologist.

How is the SMARCB1 gene linked to renal medullary carcinoma?
The development of RMC is closely tied to the SMARCB1 gene, a critical tumor suppressor.
How RMC Develops
Tumor Suppression: The SMARCB1 gene normally prevents cancerous growth.
Gene Mutation: In RMC, this gene is mutated or lost, allowing tumors to grow unchecked.
Oxygen Deprivation: Researchers believe sickled cells get trapped in the renal medulla, cutting off oxygen. This tissue death may trigger the SMARCB1 mutation.
How is renal medullary carcinoma treated, and what is the outlook?
Renal medullary carcinoma is challenging to treat, but chemotherapy, nephrectomy and clinical trials are used, and median survival has improved to approximately 12 months.
Current Treatment Options
Chemotherapy: The primary treatment used to kill fast-growing cancer cells.
Surgery (Nephrectomy): Removal of the affected kidney and nearby lymph nodes [2] to slow the spread or relieve symptoms.
Clinical Trials: Testing new combinations of chemotherapy with targeted therapy and immunotherapy.
Survival Statistics
Historical Median: Fewer than 6 months.
Current Median: Approximately 12 months.
Long-Term Goal: Increasing the percentage of patients who live beyond the one-year mark through advanced therapies.

For more information on clinical trials and current research, visit the National Cancer Institute.
Frequently Asked Questions (FAQ)
Is renal medullary carcinoma curable?
Currently, there is no known cure for RMC. However, treatments like chemotherapy and surgery are used to slow the cancer's progression and help patients live longer.
Why is RMC linked to sickle cell trait?
Researchers believe that sickled red blood cells can become trapped in the kidney's medulla, causing oxygen deprivation. This damage may lead to the genetic mutations that cause RMC.
Who is most at risk for RMC?
The highest risk group is young Black males (ages 11–39) who have sickle cell trait or sickle cell disease.
What is the first sign of RMC?
Blood in the urine (hematuria) is typically the first symptom that leads a person to seek medical attention.
How fast does RMC spread?
RMC is extremely aggressive. In most cases, the cancer has already spread to other parts of the body (metastasized) by the time it is diagnosed.
Can females get RMC?
Yes, but it is much less common. Males are diagnosed 2 to 3 times more frequently than females.
What is a nephrectomy?
A nephrectomy is a surgical procedure to remove all or part of a kidney. In RMC, the entire affected kidney and nearby lymph nodes are often removed.
What are clinical trials?
Clinical trials are research studies that test new medical treatments, such as targeted therapies or immunotherapies, to see if they are safe and effective.
Does RMC affect both kidneys?
RMC usually starts in one kidney, most frequently the right one, but it can spread to the other kidney or other organs.
What is the SMARCB1 gene?
The SMARCB1 gene is a tumor suppressor gene that normally prevents cancer. The loss or mutation of this gene is a hallmark of RMC.
Are night sweats a sign of RMC?
Yes, along with fever and unexplained weight loss, night sweats can be a systemic symptom of this aggressive cancer.
How is RMC different from other kidney cancers?
RMC is much more aggressive, affects a younger population, and has a very strong link to sickle cell conditions, unlike common types like renal cell carcinoma.
Can RMC be prevented?
There is currently no known way to prevent RMC, but individuals with sickle cell trait should be aware of the symptoms and seek prompt medical care for any urinary changes, such as blood in the urine, or persistent side or back pain.
What imaging is best for RMC?
CT scans and MRIs are the primary tools for locating the tumor, while PET scans are often used to check for spread throughout the body.
Where can I find support for an RMC diagnosis?
Patients and families should work closely with their oncology team and look for specialized rare cancer support groups and clinical trial networks.
References
Mayo Clinic Staff. Kidney cancer - Symptoms and causes. Mayo Clinic. August 17, 2024. https://www.mayoclinic.org/diseases-conditions/kidney-cancer/symptoms-causes/syc-20352664
Mayo Clinic Staff. Kidney cancer - Diagnosis and treatment. Mayo Clinic. August 17, 2024. https://www.mayoclinic.org/diseases-conditions/kidney-cancer/diagnosis-treatment/drc-20352669
Weston W, et al. Renal medullary carcinoma: a systematic review of clinical and radiological findings. Int Urol Nephrol. 2026;58(9):3407-3418. PMID 41954690. https://doi.org/10.1007/s11255-026-05113-4
Lebenthal JM, et al. Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients. Eur Urol Oncol. 2025;8(2):315-323. PMID 39013742. https://doi.org/10.1016/j.euo.2024.07.002
Medical disclaimer
The information provided in this article is for educational purposes only and is not intended as medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here. If you think you may have a medical emergency, call your doctor or 911 immediately.




Comments